Mr. Kevin David Mcclimon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 State St, Bellevue, IA 52031 Phone: 563-872-4259 Fax: 563-872-4837 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.
New Jersey Gov. John Corzine (D) on Thursday signed an executive order creating a special 11-member commission that will study the state's 81 acute care hospitals and assess whether the facilities are necessary, the AP/Philadelphia Inquirer reports.
The University of South Florida and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.
› Verified 5 days ago